Our observations that TXNRD1 transcript levels inversely associate with clinical signs of human insulin resistance in vivo and in adipocytes in vitro warrant further studies addressing the potential role of TrxR1 as a therapeutic target in diseases affecting glucose and/or lipid metabolism. Here, TXNRD1 is linked to Insulin resistance.